The Hellenic Diabetes Association (HDA) has recognised his longstanding contribution and significant role in healthcare, honouring Mr Dionysis Filiotis, President and Chief Executive Officer of Pharmaserv-Lilly for a career that has made a lasting mark on Greece’s pharmaceutical sector.
According to the announcement, the award was presented in Rethymno, the city where Mr Filiotis spent his childhood and teenage years. Returning to the place where his early dreams took shape, this time to be honoured for his overall contribution, gave the award particular significance and emotional resonance.
Mr Filiotis’s relationship with pharmaceuticals began in September 1964, when he enrolled at the School of Pharmacy of the National and Kapodistrian University of Athens. From then until today, his career has been marked by foresight, entrepreneurial vision and a steadfast commitment to healthcare. His professional path became closely linked with Lilly in 1974, while his initiative to establish Pharmaserv in 1984 and the subsequent creation of Pharmaserv-Lilly in 1994 were pivotal milestones in a long career in the Greek pharmaceutical market.
Under his leadership, Pharmaserv-Lilly grew and established itself as one of Greece’s leading pharmaceutical companies, consistently investing in scientific innovation, collaboration with the medical community and wider patient access to modern treatment options.
This year’s honour coincides with two significant anniversaries: 150 years since Lilly was founded and 32 years since Pharmaserv-Lilly was established. Both anniversaries underscore the importance of continuity, trust and a long-term commitment to scientific progress and healthcare.
Accepting the award, Mr Filiotis expressed his deep emotion and warmly thanked the President of the Hellenic Diabetes Association, Mr Konstantinos Makrylaki, as well as the Association’s members. In his speech, he highlighted the pharmaceutical sciences’ decisive contribution to managing major diseases and improving people’s lives, while also recognising the invaluable role of the medical community, particularly Greece’s diabetologists.
He paid particular tribute to his colleagues, the people with whom he had shared challenges, successes and a common vision.
“I want to share tonight’s honour with all these tireless people, because the recognition you are giving me belongs to them too,” he said, stressing that the award recognised not only one person’s career, but also the strength of collective effort and a shared commitment to a purpose centred on people.
Concluding his speech, he expressed the hope that the efforts made to improve people’s lives, the opportunities created and the paths opened over the years would serve as a valuable legacy for future generations.
The award from the Hellenic Diabetes Association is a meaningful recognition of the contribution of a figure whose name has become closely associated with the development of Greece’s pharmaceutical sector. A career that confirms how visionary leadership, steadfastness to one’s values and dedication to people can leave a lasting and meaningful mark on healthcare.